Serotype independent protection induced by a vaccine based on the IgM protease of Streptococcus suis and proposal for a new immunity-based classification systemPORCINE HEALTH MANAGEMENTIF3.12024-10-140OAAI
Broader Implications of Progressive Liver Dysfunction and Lethal Sepsis in Two Boys following Systemic High-Dose AAVMOLECULAR THERAPYIF122020-08-0163OAAI
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal modelsNATURE MEDICINEIF502019-10-0762OAAI
Suite of clinically relevant functional assays to address therapeutic efficacy and disease mechanism in the dystrophic mdx mouseJOURNAL OF APPLIED PHYSIOLOGYIF3.32017-03-014OA
Prevention of Muscular Dystrophy by an AAV Vector Encoding a Nonimmunogenic Protein Based on the Evolution of Utrophin and DystrophinMOLECULAR THERAPYIF122016-05-010OAAI
Clinico-Pathological Correlation in the Earliest Stages of Muscular Dystrophy Suggests Sensitive Physiological Parameters as Novel Primary Endpoints for Systemic Gene TherapyMOLECULAR THERAPYIF122016-05-010OAAI
A Reproducible and Reliable Non-Invasive Approach to Assess the Efficacy of Gene Therapy in mdx Mice with Relevance to Clinical TrialsMOLECULAR THERAPYIF122016-05-010OAAI
Hypersensitivity of MYH16 Fibers (M Fibers) to Myodegeneration in Canine Muscular DystrophyMOLECULAR THERAPYIF122016-05-010OAAI
Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cellsCELLULAR SIGNALLINGIF3.72011-01-0112OA